Cargando…
The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis
BACKGROUND: The global coronavirus disease 2019 (COVID-19) pandemic has necessitated considerable changes in the delivery of pharmacy services, with pharmacists experiencing increasing demands and a high rate of burnout. The ability to categorize pharmacists based on their burnout risk and associate...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519361/ https://www.ncbi.nlm.nih.gov/pubmed/36270908 http://dx.doi.org/10.1016/j.japh.2022.09.012 |
_version_ | 1784799380259209216 |
---|---|
author | Johnston, Karlee O’Reilly, Claire L. Scholz, Brett Georgousopoulou, Ekavi N. Mitchell, Imogen |
author_facet | Johnston, Karlee O’Reilly, Claire L. Scholz, Brett Georgousopoulou, Ekavi N. Mitchell, Imogen |
author_sort | Johnston, Karlee |
collection | PubMed |
description | BACKGROUND: The global coronavirus disease 2019 (COVID-19) pandemic has necessitated considerable changes in the delivery of pharmacy services, with pharmacists experiencing increasing demands and a high rate of burnout. The ability to categorize pharmacists based on their burnout risk and associated factors could be used to tailor burnout interventions. OBJECTIVE: This study aimed to identify subgroups (profiles) of pharmacists and use these profiles to describe interventions tailored to improve pharmacist’s well-being. METHODS: A survey was disseminated to pharmacists working in Australia during April and June 2020. The survey measured demographics, burnout, and psychosocial factors associated with working during COVID-19. A two-step cluster analysis was used to categorize pharmacists based on burnout and other variables. RESULTS: A total of 647 survey responses contained data that were used for analysis. Participants were mostly female (75.7%) and working full time (65.2%). The final cluster analysis yielded an acceptable two-cluster model describing 2 very different pharmacist experiences, using 10 variables. Cluster 2 (representing 53.1% of participants) describes the “affected” pharmacist, who has a high degree of burnout, works in community pharmacy, experiences incivility, is less likely to report sufficient precautionary measures in their workplace, and has had an increase in workload and overtime. In contrast, cluster 1 (representing 46.9% of participants) describes the profile of a “business as usual” hospital pharmacist with the opposite experiences. Interventions focused on the “affected” pharmacist such as financial support to employ specialized staff and equitable access to personal protective equipment should be available to community pharmacists, to reduce the risk to these frontline workers. CONCLUSION: The use of cluster analysis has identified 2 distinct profiles of pharmacists working during COVID-19. The “affected” pharmacist warrants targeted interventions to address the high burnout experienced in this group. |
format | Online Article Text |
id | pubmed-9519361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Pharmacists Association®. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95193612022-09-29 The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis Johnston, Karlee O’Reilly, Claire L. Scholz, Brett Georgousopoulou, Ekavi N. Mitchell, Imogen J Am Pharm Assoc (2003) Research BACKGROUND: The global coronavirus disease 2019 (COVID-19) pandemic has necessitated considerable changes in the delivery of pharmacy services, with pharmacists experiencing increasing demands and a high rate of burnout. The ability to categorize pharmacists based on their burnout risk and associated factors could be used to tailor burnout interventions. OBJECTIVE: This study aimed to identify subgroups (profiles) of pharmacists and use these profiles to describe interventions tailored to improve pharmacist’s well-being. METHODS: A survey was disseminated to pharmacists working in Australia during April and June 2020. The survey measured demographics, burnout, and psychosocial factors associated with working during COVID-19. A two-step cluster analysis was used to categorize pharmacists based on burnout and other variables. RESULTS: A total of 647 survey responses contained data that were used for analysis. Participants were mostly female (75.7%) and working full time (65.2%). The final cluster analysis yielded an acceptable two-cluster model describing 2 very different pharmacist experiences, using 10 variables. Cluster 2 (representing 53.1% of participants) describes the “affected” pharmacist, who has a high degree of burnout, works in community pharmacy, experiences incivility, is less likely to report sufficient precautionary measures in their workplace, and has had an increase in workload and overtime. In contrast, cluster 1 (representing 46.9% of participants) describes the profile of a “business as usual” hospital pharmacist with the opposite experiences. Interventions focused on the “affected” pharmacist such as financial support to employ specialized staff and equitable access to personal protective equipment should be available to community pharmacists, to reduce the risk to these frontline workers. CONCLUSION: The use of cluster analysis has identified 2 distinct profiles of pharmacists working during COVID-19. The “affected” pharmacist warrants targeted interventions to address the high burnout experienced in this group. American Pharmacists Association®. Published by Elsevier Inc. 2023 2022-09-29 /pmc/articles/PMC9519361/ /pubmed/36270908 http://dx.doi.org/10.1016/j.japh.2022.09.012 Text en © 2022 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Research Johnston, Karlee O’Reilly, Claire L. Scholz, Brett Georgousopoulou, Ekavi N. Mitchell, Imogen The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis |
title | The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis |
title_full | The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis |
title_fullStr | The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis |
title_full_unstemmed | The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis |
title_short | The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis |
title_sort | “affected” pharmacist and the “business as usual” pharmacist: exploring the experiences of pharmacists during covid-19 through cluster analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519361/ https://www.ncbi.nlm.nih.gov/pubmed/36270908 http://dx.doi.org/10.1016/j.japh.2022.09.012 |
work_keys_str_mv | AT johnstonkarlee theaffectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis AT oreillyclairel theaffectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis AT scholzbrett theaffectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis AT georgousopoulouekavin theaffectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis AT mitchellimogen theaffectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis AT johnstonkarlee affectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis AT oreillyclairel affectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis AT scholzbrett affectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis AT georgousopoulouekavin affectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis AT mitchellimogen affectedpharmacistandthebusinessasusualpharmacistexploringtheexperiencesofpharmacistsduringcovid19throughclusteranalysis |